Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 48% ± 16% | |
lung | 16 studies | 37% ± 14% | |
intestine | 12 studies | 31% ± 12% | |
liver | 8 studies | 33% ± 24% | |
kidney | 7 studies | 30% ± 7% | |
lymph node | 7 studies | 37% ± 11% | |
bone marrow | 6 studies | 31% ± 12% | |
uterus | 6 studies | 36% ± 18% | |
eye | 5 studies | 29% ± 8% | |
pancreas | 4 studies | 45% ± 22% | |
prostate | 4 studies | 25% ± 5% | |
breast | 4 studies | 47% ± 5% | |
brain | 4 studies | 29% ± 8% | |
placenta | 3 studies | 53% ± 11% | |
ovary | 3 studies | 20% ± 2% | |
adrenal gland | 3 studies | 35% ± 12% | |
esophagus | 3 studies | 50% ± 26% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 12266.46 | 258 / 258 | 100% | 191.48 | 230 / 230 |
liver | 100% | 11502.23 | 226 / 226 | 100% | 210.34 | 406 / 406 |
ovary | 100% | 6452.37 | 180 / 180 | 100% | 340.83 | 430 / 430 |
skin | 100% | 19384.01 | 1809 / 1809 | 100% | 408.79 | 472 / 472 |
uterus | 100% | 7626.21 | 170 / 170 | 100% | 431.20 | 459 / 459 |
esophagus | 100% | 13049.24 | 1444 / 1445 | 100% | 331.81 | 183 / 183 |
thymus | 100% | 8429.39 | 652 / 653 | 100% | 273.90 | 605 / 605 |
intestine | 100% | 9158.86 | 966 / 966 | 100% | 413.04 | 526 / 527 |
prostate | 100% | 8479.37 | 245 / 245 | 100% | 313.23 | 501 / 502 |
stomach | 100% | 7461.91 | 359 / 359 | 100% | 359.05 | 285 / 286 |
pancreas | 100% | 6744.81 | 328 / 328 | 99% | 233.06 | 177 / 178 |
bladder | 100% | 9316.81 | 21 / 21 | 99% | 416.30 | 501 / 504 |
kidney | 100% | 8967.51 | 89 / 89 | 99% | 231.42 | 895 / 901 |
breast | 100% | 10096.60 | 459 / 459 | 99% | 287.63 | 1107 / 1118 |
brain | 99% | 6042.02 | 2616 / 2642 | 100% | 243.19 | 705 / 705 |
lung | 100% | 10560.25 | 576 / 578 | 99% | 332.39 | 1146 / 1155 |
adipose | 100% | 11021.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 362.99 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 527.10 | 29 / 29 |
muscle | 100% | 13695.62 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 9379.68 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 437.79 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 280.05 | 1 / 1 |
blood vessel | 100% | 8580.23 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 7883.77 | 837 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 10639.24 | 903 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045901 | Biological process | positive regulation of translational elongation |
GO_1902255 | Biological process | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
GO_0045905 | Biological process | positive regulation of translational termination |
GO_0006414 | Biological process | translational elongation |
GO_0098586 | Biological process | cellular response to virus |
GO_0033209 | Biological process | tumor necrosis factor-mediated signaling pathway |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005643 | Cellular component | nuclear pore |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005642 | Cellular component | annulate lamellae |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0043022 | Molecular function | ribosome binding |
GO_0017070 | Molecular function | U6 snRNA binding |
GO_0003723 | Molecular function | RNA binding |
GO_0003746 | Molecular function | translation elongation factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | EIF5A |
Protein name | UORF Eukaryotic translation initiation factor 5A-1 (Eukaryotic initiation factor 5A isoform 1) (eIF-4D) Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (eIF-5A1) (Eukaryotic initiation factor 5A isoform 1) (eIF-5A) (Rev-binding factor) (eIF-4D) Eukaryotic translation initiation factor 5A (eIF-5A) |
Synonyms | EIF5A1 |
Description | FUNCTION: Translation factor that promotes translation elongation and termination, particularly upon ribosome stalling at specific amino acid sequence contexts . Binds between the exit (E) and peptidyl (P) site of the ribosome and promotes rescue of stalled ribosome: specifically required for efficient translation of polyproline-containing peptides as well as other motifs that stall the ribosome (By similarity). Acts as a ribosome quality control (RQC) cofactor by joining the RQC complex to facilitate peptidyl transfer during CAT tailing step (By similarity). Also involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity . With syntenin SDCBP, functions as a regulator of p53/TP53 and p53/TP53-dependent apoptosis . Regulates also TNF-alpha-mediated apoptosis . Mediates effects of polyamines on neuronal process extension and survival . Is required for autophagy by assisting the ribosome in translating the ATG3 protein at a specific amino acid sequence, the 'ASP-ASP-Gly' motif, leading to the increase of the efficiency of ATG3 translation and facilitation of LC3B lipidation and autophagosome formation . .; FUNCTION: (Microbial infection) Cellular cofactor of human T-cell leukemia virus type I (HTLV-1) Rex protein and of human immunodeficiency virus type 1 (HIV-1) Rev protein, essential for mRNA export of retroviral transcripts. . FUNCTION: Translation factor that promotes translation elongation and termination, particularly upon ribosome stalling at specific amino acid sequence contexts. Binds between the exit (E) and peptidyl (P) site of the ribosome and promotes rescue of stalled ribosome: specifically required for efficient translation of polyproline-containing peptides as well as other motifs that stall the ribosome. Acts as ribosome quality control (RQC) cofactor by joining the RQC complex to facilitate peptidyl transfer during CAT tailing step. . |
Accessions | ENST00000673210.1 [P63241-1] ENST00000673304.1 [P63241-1] ENST00000672765.1 [P63241-2] I3L504 ENST00000419711.6 [P63241-1] ENST00000672755.1 [P63241-1] P63241 ENST00000573542.5 [P63241-1] ENST00000416016.2 [P63241-1] I3L397 ENST00000672250.1 [P63241-1] ENST00000572815.5 ENST00000673099.1 [P63241-1] ENST00000673259.1 [P63241-1] ENST00000571955.5 [P63241-1] ENST00000336452.11 [P63241-2] ENST00000336458.13 [P63241-1] Q8WXQ9 ENST00000576930.5 [P63241-1] ENST00000573714.5 |